BRPI1014304A2 - bifidobacterium longum ncc2705 (cncm i-2618) e distúrbios imunes - Google Patents

bifidobacterium longum ncc2705 (cncm i-2618) e distúrbios imunes

Info

Publication number
BRPI1014304A2
BRPI1014304A2 BRPI1014304A BRPI1014304A BRPI1014304A2 BR PI1014304 A2 BRPI1014304 A2 BR PI1014304A2 BR PI1014304 A BRPI1014304 A BR PI1014304A BR PI1014304 A BRPI1014304 A BR PI1014304A BR PI1014304 A2 BRPI1014304 A2 BR PI1014304A2
Authority
BR
Brazil
Prior art keywords
cncm
bifidobacterium longum
immune disorders
longum ncc2705
ncc2705
Prior art date
Application number
BRPI1014304A
Other languages
English (en)
Inventor
Annick Mercenier
Clara Lucia Garcia-Rodenas
Guénolée PRIOULT
Monique Julita
Sophie Héléne Nutten
Valérie PETIT
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42646295&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI1014304(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP09159929A external-priority patent/EP2251022A1/en
Priority claimed from EP09159925A external-priority patent/EP2251020A1/en
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BRPI1014304A2 publication Critical patent/BRPI1014304A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/005—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor after treatment of microbial biomass not covered by C12N1/02 - C12N1/08
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/113—Acidophilus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/123—Bulgaricus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/125—Casei
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/151—Johnsonii
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/165—Paracasei
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/173—Reuteri
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/21—Streptococcus, lactococcus
    • A23V2400/231—Lactis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/21—Streptococcus, lactococcus
    • A23V2400/249—Thermophilus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/519—Breve
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/531—Lactis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/533—Longum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Animal Husbandry (AREA)
  • Physiology (AREA)
  • Sustainable Development (AREA)
BRPI1014304A 2009-05-11 2010-05-07 bifidobacterium longum ncc2705 (cncm i-2618) e distúrbios imunes BRPI1014304A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09159929A EP2251022A1 (en) 2009-05-11 2009-05-11 Non-replicating micro-organisms and their immune boosting effect
EP09159925A EP2251020A1 (en) 2009-05-11 2009-05-11 Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles
PCT/EP2010/056296 WO2010130663A1 (en) 2009-05-11 2010-05-07 Bifidobacterium longum ncc2705 (cncm i-2618) and immune disorders

Publications (1)

Publication Number Publication Date
BRPI1014304A2 true BRPI1014304A2 (pt) 2016-04-05

Family

ID=42646295

Family Applications (16)

Application Number Title Priority Date Filing Date
BRPI1014304A BRPI1014304A2 (pt) 2009-05-11 2010-05-07 bifidobacterium longum ncc2705 (cncm i-2618) e distúrbios imunes
BRPI1012849A BRPI1012849A2 (pt) 2009-05-11 2010-05-07 lactobacillus johnsonii la1 ncc533 (cncm i-1225) e distúrbios imunes
BRPI1010836A BRPI1010836A2 (pt) 2009-05-11 2010-05-11 nutrição medicinal especializada para pacientes cirúrgicos e de trauma contendo probióticos
BRPI1010637-5A BRPI1010637A2 (pt) 2009-05-11 2010-05-11 suplementos nutricionais orais compreendendo probióticos
BRPI1010917A BRPI1010917A2 (pt) 2009-05-11 2010-05-11 nutrição líquida completa para crianças na idade de 1 a 10 anos compreendendo probióticos.
BRPI1010839A BRPI1010839A2 (pt) 2009-05-11 2010-05-11 suplemento nutricional oral para crianças compreendendo probióticos
BRPI1010838A BRPI1010838A2 (pt) 2009-05-11 2010-05-11 espessante imediato compreendendo probióticos para alimentos e bebidas quentes ou frios a serem administrados a pacientes disfágicos
BRPI1010912A BRPI1010912A2 (pt) 2009-05-11 2010-05-11 módulos contendo probióticos para alimentação por sonda.
BRPI1013733A BRPI1013733A2 (pt) 2009-05-11 2010-05-11 cereais do café da manhã contendo micro-organismos probióticos
BRPI1010926A BRPI1010926A2 (pt) 2009-05-11 2010-05-11 fórmulas para alimentação infantil compreendendo micro-organismos probióticos.
BRPI1010916A BRPI1010916A2 (pt) 2009-05-11 2010-05-11 fórmula nutricional especializada para pacientes adultos com intolerância gastrointestinal contendo probióticos.
BRPI1010802A BRPI1010802A2 (pt) 2009-05-11 2010-05-11 preparações de leite integral seco contendo micro-organismos
BRPI1010929A BRPI1010929A2 (pt) 2009-05-11 2010-05-11 fórmula de alimentação para bebê e crianças jovens compreendendo probióticos para bebês e crianças jovens.
BRPI1010574A BRPI1010574A2 (pt) 2009-05-11 2010-05-11 cereal infantil compreendendo micro-organismos probióticos não replicantes.
BRPI1013731A BRPI1013731A2 (pt) 2009-05-11 2010-05-11 leite de crescimento contendo micro-organismos probioticos
BRPI1010919A BRPI1010919A2 (pt) 2009-05-11 2010-05-11 fórmula para alimentação por sonda padrão nutricionalmente balanceada contendo probióticos.

Family Applications After (15)

Application Number Title Priority Date Filing Date
BRPI1012849A BRPI1012849A2 (pt) 2009-05-11 2010-05-07 lactobacillus johnsonii la1 ncc533 (cncm i-1225) e distúrbios imunes
BRPI1010836A BRPI1010836A2 (pt) 2009-05-11 2010-05-11 nutrição medicinal especializada para pacientes cirúrgicos e de trauma contendo probióticos
BRPI1010637-5A BRPI1010637A2 (pt) 2009-05-11 2010-05-11 suplementos nutricionais orais compreendendo probióticos
BRPI1010917A BRPI1010917A2 (pt) 2009-05-11 2010-05-11 nutrição líquida completa para crianças na idade de 1 a 10 anos compreendendo probióticos.
BRPI1010839A BRPI1010839A2 (pt) 2009-05-11 2010-05-11 suplemento nutricional oral para crianças compreendendo probióticos
BRPI1010838A BRPI1010838A2 (pt) 2009-05-11 2010-05-11 espessante imediato compreendendo probióticos para alimentos e bebidas quentes ou frios a serem administrados a pacientes disfágicos
BRPI1010912A BRPI1010912A2 (pt) 2009-05-11 2010-05-11 módulos contendo probióticos para alimentação por sonda.
BRPI1013733A BRPI1013733A2 (pt) 2009-05-11 2010-05-11 cereais do café da manhã contendo micro-organismos probióticos
BRPI1010926A BRPI1010926A2 (pt) 2009-05-11 2010-05-11 fórmulas para alimentação infantil compreendendo micro-organismos probióticos.
BRPI1010916A BRPI1010916A2 (pt) 2009-05-11 2010-05-11 fórmula nutricional especializada para pacientes adultos com intolerância gastrointestinal contendo probióticos.
BRPI1010802A BRPI1010802A2 (pt) 2009-05-11 2010-05-11 preparações de leite integral seco contendo micro-organismos
BRPI1010929A BRPI1010929A2 (pt) 2009-05-11 2010-05-11 fórmula de alimentação para bebê e crianças jovens compreendendo probióticos para bebês e crianças jovens.
BRPI1010574A BRPI1010574A2 (pt) 2009-05-11 2010-05-11 cereal infantil compreendendo micro-organismos probióticos não replicantes.
BRPI1013731A BRPI1013731A2 (pt) 2009-05-11 2010-05-11 leite de crescimento contendo micro-organismos probioticos
BRPI1010919A BRPI1010919A2 (pt) 2009-05-11 2010-05-11 fórmula para alimentação por sonda padrão nutricionalmente balanceada contendo probióticos.

Country Status (20)

Country Link
US (18) US10576110B2 (pt)
EP (16) EP2429539B1 (pt)
JP (16) JP2012526752A (pt)
CN (16) CN102802648A (pt)
AR (2) AR076676A1 (pt)
AU (3) AU2010247469B2 (pt)
BR (16) BRPI1014304A2 (pt)
CA (12) CA2761573A1 (pt)
CL (1) CL2011002818A1 (pt)
ES (4) ES2608651T3 (pt)
MX (7) MX336030B (pt)
MY (4) MY165388A (pt)
PL (2) PL2429557T3 (pt)
PT (2) PT2429539T (pt)
RU (6) RU2556124C2 (pt)
SG (1) SG175167A1 (pt)
TW (2) TWI489988B (pt)
UA (1) UA109876C2 (pt)
WO (16) WO2010130662A1 (pt)
ZA (4) ZA201109095B (pt)

Families Citing this family (109)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102802648A (zh) 2009-05-11 2012-11-28 雀巢产品技术援助有限公司 约氏乳杆菌La1 NCC533(CNCM I-1225)和免疫病症
EP2397145A1 (en) * 2010-06-18 2011-12-21 Nestec S.A. L. johnsonii La1, B. longum NCC2705 and immune disorders
EP2449887B1 (en) * 2010-11-05 2016-01-06 Nestec S.A. Method for preparing pet food containing probiotic micro-organisms
EP2449891A1 (en) * 2010-11-05 2012-05-09 Nestec S.A. Drinking yoghurt preparations containing non-replicating probiotic micro-organisms
EP2455093A1 (en) * 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic bacteria and prevention or treatment of infections in children
EP2455094A1 (en) 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect children against gastrointestinal infections
EP2455092A1 (en) * 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
EP2658547A1 (en) 2010-12-31 2013-11-06 Abbott Laboratories Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
NZ612504A (en) 2010-12-31 2015-02-27 Abbott Lab Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
JP5821128B2 (ja) * 2011-02-18 2015-11-24 国立大学法人広島大学 大腸粘膜組織の免疫制御組成物
ES2667033T3 (es) 2011-03-01 2018-05-09 Nestec S.A. Viscosidad extensional para favorecer una deglución segura de los bolos de alimentos
CN103582698B (zh) 2011-03-29 2016-08-17 雀巢产品技术援助有限公司 缺失d-乳酸产生的约氏乳杆菌菌株cncm i-1225的天然衍生物
SG193521A1 (en) 2011-03-29 2013-10-30 Nestec Sa Derivative of the lactobacilus johnsonii strain cncm i-1225, deficient in d-lactic acid production and with an improved shelf life
CN103649306B (zh) 2011-03-29 2015-07-01 雀巢产品技术援助有限公司 在d乳酸生产中有缺陷以及具有改善的免疫特征的约氏乳杆菌菌株cncm i-1225的天然衍生物
WO2012130965A1 (en) 2011-03-29 2012-10-04 Nestec S.A. Natural derivative of a well known and successful probiotic strain deficient in d-lactic acid production
BR112013025047A2 (pt) * 2011-03-31 2017-02-14 Nestec Sa composições nutricionais para aumentar os níveis de arginina e métodos para usar as mesmas
TR201809987T4 (tr) 2011-06-20 2018-08-27 Heinz Co Brands H J Llc Probiyotik bileşimler ve yöntemler.
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
US11446316B2 (en) 2011-07-22 2022-09-20 Abbott Laboratories Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
BR112014004772A2 (pt) 2011-08-29 2017-03-21 Abbott Lab oligossacarídeos do leite humano para evitar danos e/ou promover a cura do trato gastrointestinal
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
US20150159066A1 (en) 2011-11-25 2015-06-11 Smith & Nephew Plc Composition, apparatus, kit and method and uses thereof
WO2013087916A1 (en) * 2011-12-15 2013-06-20 Nestec S.A. Extensional viscosity to promote safe swallowing of food boluses
FR2984352B1 (fr) * 2011-12-16 2018-02-16 Lesaffre Et Compagnie Composition comprenant une biomasse microbienne active
CN104780932A (zh) 2012-02-29 2015-07-15 伊西康内外科公司 微生物区系的组合物及与其相关的方法
US20130344042A1 (en) * 2012-06-20 2013-12-26 Gretchen Tanbonliong Dietary management of celiac disease and food allergy
CN102715235B (zh) * 2012-07-10 2013-09-11 武汉光明乳品有限公司 一种活性植物乳杆菌饮品及其制备方法
CN102949416B (zh) * 2012-11-23 2018-12-11 西安泰科迈医药科技股份有限公司 一种用于改善胃肠道功能的药物组合物及其制备方法
RU2015125548A (ru) 2012-11-29 2017-01-11 Нестек С.А. Синбиотическая композиция и ее использование
FR2999933B1 (fr) * 2012-12-21 2020-01-31 Société des Produits Nestlé S.A. Utilisation de microorganismes probiotiques comme agent favorisant la synthese de melanine
CN103006825A (zh) * 2012-12-21 2013-04-03 林树芳 一种辅助治疗胃病疾患的药膳食品
FR2999932B1 (fr) * 2012-12-21 2020-01-31 Société des Produits Nestlé S.A. Utilisation de microorganismes probiotiques comme agent favorisant la synthese de melanine
US11179427B2 (en) 2013-01-21 2021-11-23 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
WO2014125099A1 (en) * 2013-02-15 2014-08-21 Nestec S.A. Food composition and its use
RU2015143729A (ru) 2013-03-15 2017-04-21 СМИТ ЭНД НЕФЬЮ ПиЭлСи Раневая повязка и способ лечения
WO2014154793A1 (en) * 2013-03-28 2014-10-02 Fresenius Kabi Deutschland Gmbh Compositions for use in nutrition of dysphagia patients
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
CN104120093B (zh) * 2013-04-26 2016-12-28 中国农业大学 长双歧杆菌及其应用以及功能食品组合物及其制备方法
BR112015028164B1 (pt) 2013-05-10 2022-02-08 H.J. Heinz Company Brands Llc Usos da bactéria probiótica, lactobacillus paracasei, para tratar uma infecção microbiana e para prevenir ou reduzir a gravidade de uma infecção microbiana
CN105658226B (zh) * 2013-08-16 2019-05-14 港大科桥有限公司 使用益生菌治疗癌症的方法和组合物
CN103621633B (zh) * 2013-12-05 2015-02-04 刘保惠 一种婴幼儿系列牦牛奶配方奶粉及其制备方法
WO2015087919A1 (ja) * 2013-12-10 2015-06-18 株式会社明治 抗菌ペプチド誘導剤
CN103636779A (zh) * 2013-12-17 2014-03-19 山东兴牛乳业有限公司 一种功能性发酵乳及其制备方法
FR3020949B1 (fr) * 2014-05-16 2018-02-09 Ecole Normale Superieure De Lyon Composition permettant de favoriser la croissance juvenile humaine et animale en cas de malnutrition
CN105176857B (zh) * 2014-06-12 2019-02-12 暨南大学 具有氨苄青霉素抗性的长双歧杆菌及其制剂的制备与应用
EP3212001A4 (en) 2014-10-31 2018-04-25 Whole Biome Inc. Methods and compositions relating to microbial treatment and diagnosis of disorders
CN104473292A (zh) * 2014-12-22 2015-04-01 威海百合生物技术股份有限公司 一种婴幼儿益生菌固体饮料
SG10202105996WA (en) 2014-12-23 2021-07-29 4D Pharma Res Ltd Pirin polypeptide and immune modulation
KR20220151045A (ko) 2014-12-23 2022-11-11 4디 파마 리서치 리미티드 면역 조정
TWI788111B (zh) 2015-01-02 2022-12-21 美商梅拉洛伊卡公司 多元補充品組成物
TWI790189B (zh) * 2015-01-02 2023-01-21 美商梅拉洛伊卡公司 細菌組成物
US10137164B2 (en) 2015-01-02 2018-11-27 Melaleuca, Inc. Dietary supplement compositions
JP6666053B2 (ja) * 2015-03-31 2020-03-13 雪印メグミルク株式会社 Ｉａｌｄ産生促進剤
CN104770469A (zh) * 2015-04-17 2015-07-15 武汉百信正源生物技术工程有限公司 一种具有增强免疫力功能的酸驴奶的制备方法
DK3292135T3 (da) 2015-05-06 2022-10-31 Univ Wageningen Anvendelse af et polypeptid til at fremkalde immunsignalering og/eller påvirke tarmbarrierefunktion og/eller modulere metabolsk status
WO2016183535A1 (en) 2015-05-14 2016-11-17 University Of Puerto Rico Methods for restoring microbiota of newborns
MY188694A (en) * 2015-05-29 2021-12-23 Meiji Co Ltd Anticariogenic agent and anticariogenic composition
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
RS59308B1 (sr) 2015-06-15 2019-10-31 4D Pharma Res Ltd Kompozicije koje sadrže bakterijske sojeve
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MD3240554T2 (ro) 2015-06-15 2020-01-31 4D Pharma Res Ltd Blautia stercosis și wexlerae pentru utilizare în tratarea bolilor inflamatorii și autoimune
PL3206700T3 (pl) 2015-06-15 2019-11-29 4D Pharma Res Ltd Kompozycje zawierające szczepy bakteryjne
CN105166633A (zh) * 2015-07-20 2015-12-23 龚启萍 一种添加益生菌的婴儿米粉的加工方法
JP2018525390A (ja) * 2015-08-31 2018-09-06 ネステク ソシエテ アノニム 抑うつ症状を治療又は予防するための、ビフィドバクテリウム・ロンガムを用いる、方法及び組成物
DK3626081T3 (da) 2015-09-10 2022-02-28 Univ Catholique Louvain Pasteuriseret akkermansia til fremme af vægttab
KR20170032815A (ko) * 2015-09-15 2017-03-23 경희대학교 산학협력단 신규 유산균 및 퇴행성 뇌질환 또는 인지기능의 예방, 개선 또는 치료용 조성물
US20170079310A1 (en) * 2015-09-18 2017-03-23 Richard Gerry Dingman, JR. Texture analog dysphagia cuisine
KR20180056775A (ko) 2015-10-07 2018-05-29 갈데르마 리써어치 앤드 디벨로프먼트 유산균 함유 조성물 및 아토피 피부염을 치료하기 위한 이의 용도
ME03003B (me) 2015-11-20 2018-10-20 4D Pharma Res Ltd Kompozicije koje sadrže bakterijske sojeve
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
EP3173373A1 (en) 2015-11-26 2017-05-31 Anheuser-Busch InBev S.A. Polymeric keg connector
US11564667B2 (en) 2015-12-28 2023-01-31 New York University Device and method of restoring microbiota of newborns
TWI724099B (zh) * 2016-01-28 2021-04-11 日商康貝股份有限公司 用於改善或預防疱疹病毒感染症之組合物
CN105661017A (zh) * 2016-02-03 2016-06-15 程雪娇 一种牲畜饲料及制备方法
RS58869B1 (sr) 2016-03-04 2019-08-30 4D Pharma Plc Kompozicije koje sadrže blautia bakterijske sojeve za lečenje visceralne hipersenzitivnosti
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
TW201821093A (zh) 2016-07-13 2018-06-16 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
EP3272396A1 (en) * 2016-07-18 2018-01-24 Bionou Research, S.L. Use of probiotics in the treatment and/or prevention of atopic dermatitis
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
BE1025110B1 (fr) 2016-12-16 2018-10-29 Nestle Skin Health Capsule comprenant un microorganisme probiotique pour utilisation dans un dispositif de production et de distribution de compositions
WO2018180728A1 (ja) * 2017-03-30 2018-10-04 森永乳業株式会社 炎症制御遺伝子の発現促進用組成物
CN107772264A (zh) * 2017-05-12 2018-03-09 南昌大学 一种具有排汞功能的南瓜果胶排汞婴幼儿米粉的制备方法
TWI787272B (zh) 2017-05-22 2022-12-21 英商4D製藥研究有限公司 包含細菌菌株之組合物
JP6978514B2 (ja) 2017-05-24 2021-12-08 フォーディー ファーマ リサーチ リミテッド4D Pharma Research Limited 細菌株を含む組成物
JP6884889B2 (ja) 2017-06-14 2021-06-09 フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ 細菌株を含む組成物
KR20200015575A (ko) 2017-06-14 2020-02-12 4디 파마 리서치 리미티드 세균 균주를 포함하는 조성물
FR3070167B1 (fr) * 2017-08-17 2021-12-24 Ecole Normale Superieure Lyon Souches de lactobacillus stimulant la croissance
CN111372596A (zh) 2017-08-30 2020-07-03 潘德勒姆治疗公司 用于治疗微生物组相关病症的方法和组合物
JP7065589B2 (ja) * 2017-10-31 2022-05-12 株式会社明治 ＩＬ－１β血清濃度低下用発酵乳、ＣＸＣＬ１血清濃度低下用発酵乳、癌に伴うＩＬ－１βの過度な血清濃度上昇の抑制用発酵乳、または、癌に伴うＣＸＣＬ１の過度な血清濃度上昇の抑制用発酵乳
CN108013473B (zh) * 2017-11-20 2021-06-18 陕西海升果业发展股份有限公司 一种益生菌冻干块及制备方法以及基于该冻干块的即食水果谷物麦片及制备方法
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
CN108077935A (zh) * 2018-01-22 2018-05-29 广东格物生物科技有限公司 调理中老年人肠道功能菌剂及其制备方法和应用
JP6846376B2 (ja) * 2018-03-15 2021-03-24 キリンホールディングス株式会社 皮膚状態改善用組成物
BR112021005316A2 (pt) * 2018-10-02 2021-06-15 Société des Produits Nestlé S.A. combinação de probióticos para o tratamento de distúrbios gastrointestinais relacionados à inflamação
WO2020113485A1 (zh) * 2018-12-06 2020-06-11 江苏安惠生物科技有限公司 调节肠道菌群的胶囊
CN109628359B (zh) * 2019-02-22 2021-03-02 江南大学 一株可缓解过敏性哮喘的罗伊氏乳杆菌及其应用
TWI729384B (zh) 2019-04-26 2021-06-01 大江生醫股份有限公司 泌尿生殖道保健之益生菌株及其用途
JP7013419B2 (ja) * 2019-08-07 2022-02-15 日清食品ホールディングス株式会社 炎症性サイトカインの産生誘導活性は低いが抗炎症性サイトカインの産生誘導活性が高いビフィズス菌
CN110777087B (zh) * 2019-08-09 2020-08-07 四川厌氧生物科技有限责任公司 一种约氏乳杆菌及其应用
CN110521938A (zh) * 2019-09-12 2019-12-03 广东金海康医学营养品股份有限公司 一种婴幼儿营养米粉及其制备方法
CN110638845B (zh) * 2019-11-08 2020-07-14 爱优诺营养品有限公司 一种菌剂组合物及其在改善厌食症功能性奶粉上的应用
KR102135879B1 (ko) * 2020-02-13 2020-07-21 주식회사 케이티앤지 신규 락토바실러스 플란타룸(Lactobacillus plantarum) KC3 균주를 이용한 면역장애, 호흡기 염증 질환, 알레르기 및 천식의 예방 또는 치료용 조성물 및 이의 용도
EP4346451A1 (en) * 2021-05-27 2024-04-10 Compagnie Gervais Danone Cereal-based compositions with a mix of galacto-oligosaccharides/fructo- oligosaccharides and uses thereof for improving iron absorption
CN113025540B (zh) * 2021-05-28 2021-10-01 中国食品发酵工业研究院有限公司 用于发酵大豆蛋白的乳酸菌菌剂、制备方法、发酵方法、具有增肌功能的发酵产物
WO2023104887A1 (en) * 2021-12-09 2023-06-15 Société des Produits Nestlé S.A. Lactobacillus acidophilus to increase agmatine production by microbiota
CN115428954A (zh) * 2022-09-15 2022-12-06 北京三元食品股份有限公司 复合益生菌及发酵乳在制备用于辅助治疗hiv患者产品中的应用
WO2024105265A1 (fr) 2022-11-17 2024-05-23 Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement Limosilactobacillus mucosae et désordres nécessitant un accroissement du niveau de glp-1

Family Cites Families (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1456207A (en) * 1972-12-15 1976-11-24 Unilever Ltd Ice-cream
GB2225922B (en) 1988-12-16 1992-10-07 Samuel Kuria Mbugua A method for the manufacture of a fermented cereal product
US4980182A (en) * 1989-06-21 1990-12-25 Nestec S.A. Beverages containing a beverage base and milk protein
DK0577903T3 (da) * 1992-07-06 1998-04-06 Nestle Sa Antigastritisk middel
US5308832A (en) * 1992-07-27 1994-05-03 Abbott Laboratories Nutritional product for persons having a neurological injury
US5494687A (en) * 1993-11-05 1996-02-27 Polster; Louis S. Process for tenderizing meat
US5714472A (en) * 1993-12-23 1998-02-03 Nestec Ltd. Enternal formulation designed for optimized nutrient absorption and wound healing
US5549905A (en) * 1994-10-18 1996-08-27 Clintec Nutrition Co. Enternal composition for pediatric patients
US5533973A (en) * 1995-01-13 1996-07-09 Abbott Laboratories Alteration of nutritional product during enteral tube feeding
US5733884A (en) * 1995-11-07 1998-03-31 Nestec Ltd. Enteral formulation designed for optimized wound healing
US5902578A (en) * 1996-03-25 1999-05-11 Abbott Laboratories Method and formula for the prevention of diarrhea
US6194009B1 (en) * 1996-11-22 2001-02-27 Princeton Nutrition, Llc Refrigeration-shelf-stable ultra-pasteurized or pasteurized infant formula
ATE206873T1 (de) * 1997-01-09 2001-11-15 Nestle Sa Probiotik enthaltendes getreideprodukt
US7374753B1 (en) * 1997-06-03 2008-05-20 Ganeden Biotech, Inc. Probiotic lactic acid bacterium to treat bacterial infections associated with SIDS
US6200950B1 (en) * 1998-02-18 2001-03-13 Nestec S.A. Calorically dense nutritional composition
DE19836339B4 (de) * 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
DE19860375A1 (de) 1998-12-28 2000-07-06 Aventis Res & Tech Gmbh & Co Alpha Amylase-resistente Stärke zur Herstellung von Nahrungs- und Arzneimittel
US6120814A (en) * 1999-02-22 2000-09-19 Nature's One, Inc. Organic nutritional formula
EP1034788A1 (en) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactic acid bacteria strains capable of preventing diarrhea
BR0008920A (pt) * 1999-03-11 2001-12-18 Nestle Sa Cepas de lactobacillus capazes de prevenirdiarréia causada por bactéria patogênica erotaviroses
EP1034787A1 (en) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
FR2795917B1 (fr) 1999-07-06 2001-08-31 Gervais Danone Sa Procede de preparation d'un produit lacte immunostimulant et ses applications
ES2239622T3 (es) * 1999-10-26 2005-10-01 Societe Des Produits Nestle S.A. Bacterias del acido lactico para el tratamiento y/o profilaxis de giardiasis.
EP1110555A1 (fr) * 1999-12-22 2001-06-27 Societe Des Produits Nestle S.A. Agent anti-adhesion de la flore pathogene de la peau
AU784898B2 (en) * 2000-01-18 2006-07-20 Societe Des Produits Nestle S.A. Pet food composition for treating helicobacter species in pets
AU783439C (en) * 2000-03-24 2006-12-14 Societe Des Produits Nestle S.A. Use of lactic acid bacterium for the prevention of peritonitis
MXPA02009763A (es) * 2000-04-04 2003-03-27 Shionogi & Co Composiciones aceitosas las cuales contienen farmacos altamente solubles en grasa.
JP2004514424A (ja) * 2000-09-25 2004-05-20 ソシエテ　デ　プロデユイ　ネツスル　ソシエテ　アノニム アレルギー反応を起こす個人の傾向を減少させることができる乳酸菌
ES2357419T3 (es) * 2000-10-06 2011-04-26 Nestec S.A. Uso de bacterias probióticas productoras de ácido láctico para proteger la piel contra reacciones inflamatorias, alérgicas o inmunosupresoras causadas por la radiación ultravioleta.
EP1227152A1 (en) * 2001-01-30 2002-07-31 Société des Produits Nestlé S.A. Bacterial strain and genome of bifidobacterium
EP1408760B1 (en) * 2001-02-19 2009-04-01 Société des Produits Nestlé S.A. Consumable product containing probiotics
EP1239032A1 (en) * 2001-03-02 2002-09-11 Société des Produits Nestlé S.A. Lactic acid bacteria as agents for treating and preventing allergy
EP1260227A1 (en) * 2001-05-23 2002-11-27 Societe Des Produits Nestle S.A. Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
EP2260725A3 (en) * 2001-08-02 2013-01-02 Simply Thick LLC Process for Preparing Concentrate Thickener Compositions
PT1478329E (pt) * 2002-02-21 2006-09-29 Nestle Sa Composicao administravel por via oral para fotoproteccao da pele
EP1364586A1 (en) * 2002-05-24 2003-11-26 Nestec S.A. Probiotics and oral tolerance
EP1384483A1 (en) * 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
ITBO20020564A1 (it) * 2002-09-06 2004-03-07 Alfa Wassermann Spa Bifidobatteri e preparazioni che li contengono.
US7105336B2 (en) * 2002-10-07 2006-09-12 Biogaia Ab Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
WO2004069156A2 (en) * 2003-01-30 2004-08-19 The Regents Of The University Of California Inactivated probiotic bacteria and methods of use thereof
CN1183960C (zh) * 2003-02-27 2005-01-12 四川大学 双歧杆菌细胞壁蛋白在制药中的应用
JP4038450B2 (ja) * 2003-03-31 2008-01-23 株式会社バイオテックジャパン 低カロリーご飯並びに低カロリー米及びそれらの製造方法
ES2355382T3 (es) * 2003-06-23 2011-03-25 Nestec S.A. Fórmula para lactantes o de continuación.
EP1638414B1 (en) * 2003-06-23 2009-06-17 Nestec S.A. Infant or follow-on formula
PT1638416E (pt) * 2003-06-23 2013-07-08 Nestec Sa Utilização de uma fórmula nutricional para função de barreira intestinal óptima
EP2033529B1 (en) * 2003-10-24 2019-12-11 N.V. Nutricia Synbiotic composition for infants
WO2005091933A2 (en) * 2004-03-04 2005-10-06 E-L Management Corporation Skin treatment method with lactobacillus extract
US7090879B2 (en) * 2004-03-18 2006-08-15 Abbott Laboratories Nutritional formula containing select carotenoid combinations
US20070224126A1 (en) 2004-06-01 2007-09-27 Therese Dufresne Index and Method of use of Adapted Food Compositions for Dysphagic Persons
AU2005257033B2 (en) * 2004-06-23 2011-05-12 L'oreal Method and compositions useful for preventing and/or treating sensitive and/or dry skin
ATE361101T1 (de) * 2004-08-24 2007-05-15 Nutricia Nv Nahrungszusammensetzung die unverdauliche oligosaccharide enthält
JP5371169B2 (ja) * 2004-09-24 2013-12-18 コンビ株式会社 薬剤耐性菌感染防除剤
BRPI0516437A (pt) * 2004-10-04 2008-09-02 Oreal E Nestec S A L utilização de uma quantidade eficaz de pelo menos um microorganismo, processo de tratamento cosmético, composição cosmética e/ou dermatológica e composição para absorção oral
DE602004013848D1 (de) * 2004-11-12 2008-06-26 Nutricia Nv Flüssige übergangsnahrung für kleinkinder
ATE434389T1 (de) * 2004-11-18 2009-07-15 Nutricia Nv Verdickungsmittelzusammensetzung für dysphagia- patienten
ATE473636T1 (de) * 2005-02-15 2010-07-15 Barry R Goldin Nahrungsmittel mit probiotischem und isoliertem beta-glukan und verwendungsverfahren dafür
TR201820329T4 (tr) * 2005-02-28 2019-01-21 Nutricia Nv Probiyotik İçeren Besin Bileşimi
CA2537452C (en) * 2005-03-09 2013-12-24 Abbott Laboratories Concentrated human milk fortifier liquid
CA2604338A1 (en) * 2005-04-13 2006-10-19 Nestec S.A. Infant formula with probiotics
US20060251634A1 (en) * 2005-05-06 2006-11-09 Ho-Jin Kang Method of improving immune function in mammals using lactobacillus strains with certain lipids
BRPI0613805A2 (pt) * 2005-07-20 2011-02-15 Unilever Nv método de preparação de um produto comestìvel e produto comestìvel
WO2007020884A1 (ja) 2005-08-12 2007-02-22 Meiji Dairies Corporation β－ディフェンシンを介した感染予防効果を有するビフィズス菌または乳酸菌とそれを含有する食品・医薬品組成物
ATE451845T1 (de) * 2005-10-05 2010-01-15 Nestec Sa Verwendung einer nährstoffformulierung zur förderung des aufholwachstums
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
WO2007050656A2 (en) * 2005-10-24 2007-05-03 Nestec S.A. Dietary fiber formulation and method of administration
PT1800675E (pt) * 2005-12-23 2011-08-30 Nutricia Nv COMPOSIÇÃO CONTENDO ÁCIDOS GORDOS POLI-INSATURADOS, PROTEÍNAS E MANGANjS E/OU MOLIBDÉNIO PARA O MELHORAMENTO DA COMPOSIÇÃO DA MEMBRANA
US7758906B2 (en) 2006-01-20 2010-07-20 Kraft Foods Global Brands Llc Thickening system for products prepared with milk
WO2007093619A1 (en) * 2006-02-15 2007-08-23 Nestec S.A. Use of bifidobacterium longum for the prevention and treatment of inflammation
MY149913A (en) 2006-03-07 2013-10-31 Nestec Sa Synbiotic mixture
GB0612671D0 (en) * 2006-06-27 2006-08-09 Shs Int Ltd Nutritional formulation
ES2557160T3 (es) 2006-10-23 2016-01-22 Nestec S.A. Modulación del aroma y el sabor mediante biotransformación en productos lácteos
WO2008106372A1 (en) 2007-02-28 2008-09-04 Mead Johnson Nutrition Company Method for treating or preventing systemic inflammation
WO2008137181A1 (en) 2007-05-07 2008-11-13 Clearly Superior, Inc Food thickening agent, method for producing food thickening agent
JP2008283922A (ja) * 2007-05-18 2008-11-27 Fuji Oil Co Ltd ヨーグルト様飲食品の製造法
EP1992351B1 (en) 2007-05-18 2016-05-11 Nestec S.A. Lactobacillus johnsonii for prevention of postsurgical infection
WO2008153377A1 (en) * 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
US20110008502A1 (en) * 2007-07-02 2011-01-13 San-Ei Gen F.F.I., Inc. Processed food composition containing dextrin
US20090041727A1 (en) * 2007-08-08 2009-02-12 Conjugon, Inc. Compositions and Methods for Microbe Storage and Delivery
EP2022502A1 (en) * 2007-08-10 2009-02-11 Nestec S.A. Lactobacillus rhamnosus and weight control
US9113641B2 (en) * 2007-12-06 2015-08-25 Arla Foods Amba Probiotic bacteria and regulation of fat storage
BRPI0821165B8 (pt) 2007-12-07 2021-05-25 Nutricia Nv uso de uma composição
WO2009075564A1 (en) * 2007-12-10 2009-06-18 N.V. Nutricia Paediatric fibre mixture
US20090162499A1 (en) * 2007-12-21 2009-06-25 The Quaker Oats Company Grain products having a potent natural sweetener and a bulking agent
ES2395838T3 (es) * 2007-12-21 2013-02-15 Compagnie Gervais Danone Método para disminuir el contorno abdominal administrando una bacteria del tipo Bifidobacterium
EP2110027A1 (en) * 2008-04-01 2009-10-21 Nestec S.A. Long-chain polyunsaturated fatty acids (LC-PUFA) in maternal nutrition during pregnancy and lactation
US20120039860A1 (en) * 2008-04-10 2012-02-16 Nestec S.A. Compositions and methods for improved oral health
ES2656776T3 (es) 2008-06-13 2018-02-28 N.V. Nutricia Composición nutricional para bebés nacidos por cesárea
EP2140772A1 (en) 2008-07-03 2010-01-06 Nestec S.A. Temperature-induced delivery of nutrients by micro-organisms in the gastrointestinal tract
US8137718B2 (en) * 2008-09-19 2012-03-20 Mead Johnson Nutrition Company Probiotic infant products
US20100074870A1 (en) * 2008-09-19 2010-03-25 Bristol-Myers Squibb Company Probiotic infant products
JP2010095465A (ja) * 2008-10-16 2010-04-30 House Wellness Foods Kk 乳酸菌含有免疫賦活用組成物
US9034314B2 (en) * 2008-11-03 2015-05-19 Nestec S.A. Nutritional composition comprising probiotics and improving sleep patterns
CN102802648A (zh) 2009-05-11 2012-11-28 雀巢产品技术援助有限公司 约氏乳杆菌La1 NCC533(CNCM I-1225)和免疫病症
EP2251022A1 (en) * 2009-05-11 2010-11-17 Nestec S.A. Non-replicating micro-organisms and their immune boosting effect
EP2251020A1 (en) * 2009-05-11 2010-11-17 Nestec S.A. Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles
ES2382263T3 (es) 2009-05-11 2012-06-06 Nestec S.A. Prevención y tratamiento de la diarrea alérgica
EP2308498A1 (en) 2009-09-30 2011-04-13 Nestec S.A. Administration of Bifidobacterium breve during infancy to prevent inflammation later in life
US9226521B2 (en) 2009-12-08 2016-01-05 Nestec S.A. Infant formula with probiotics and milk fat globule membrane components
KR101166798B1 (ko) * 2011-12-19 2012-07-26 김대현 락토바실러스 애시도필러스 엘비의 사균을 포함하는 알레르기 질환의 치료 또는 예방용 의약 조성물

Also Published As

Publication number Publication date
US20130028877A1 (en) 2013-01-31
CN102917714A (zh) 2013-02-06
AR076677A1 (es) 2011-06-29
AU2010247469A1 (en) 2011-12-08
AU2010251313A1 (en) 2011-11-17
CN103648510A (zh) 2014-03-19
JP2012526754A (ja) 2012-11-01
EP2429543A1 (en) 2012-03-21
EP2429549A1 (en) 2012-03-21
US20120195867A1 (en) 2012-08-02
PL2429556T3 (pl) 2017-01-31
BRPI1010912A2 (pt) 2019-09-24
RU2011150216A (ru) 2013-06-20
CN103052395A (zh) 2013-04-17
CN102811725A (zh) 2012-12-05
TWI402075B (zh) 2013-07-21
MY165388A (en) 2018-03-21
CL2011002818A1 (es) 2012-05-11
AU2010247469B2 (en) 2014-12-18
EP2429539B1 (en) 2016-10-12
EP2429540B1 (en) 2016-07-27
BRPI1010916A2 (pt) 2019-09-24
JP2016006054A (ja) 2016-01-14
CN102844037A (zh) 2012-12-26
RU2564139C2 (ru) 2015-09-27
EP2429557B2 (en) 2024-05-22
CA2761689A1 (en) 2010-11-18
BRPI1010574A2 (pt) 2016-03-15
EP2429550A1 (en) 2012-03-21
EP2429546B1 (en) 2016-08-31
RU2011150214A (ru) 2013-06-20
US20120114701A1 (en) 2012-05-10
CN102858354B (zh) 2015-06-17
BRPI1010802A2 (pt) 2016-04-05
MX339112B (es) 2016-05-12
MX2011012064A (es) 2011-12-06
CN104220082A (zh) 2014-12-17
PL2429557T3 (pl) 2018-06-29
MX2011012070A (es) 2012-03-07
US20120064051A1 (en) 2012-03-15
JP2012526752A (ja) 2012-11-01
CN102695519A (zh) 2012-09-26
WO2010139531A1 (en) 2010-12-09
JP2012526756A (ja) 2012-11-01
WO2011000620A1 (en) 2011-01-06
MX2011012066A (es) 2012-03-07
ZA201109091B (en) 2013-05-29
US20130260440A1 (en) 2013-10-03
MX338680B (es) 2016-04-27
AU2010255972A1 (en) 2011-12-08
CN102770145A (zh) 2012-11-07
CN102595916A (zh) 2012-07-18
RU2011150192A (ru) 2013-06-20
RU2011150197A (ru) 2013-06-20
BRPI1010637A2 (pt) 2019-04-02
WO2010130702A1 (en) 2010-11-18
EP2429548A1 (en) 2012-03-21
WO2010130713A1 (en) 2010-11-18
JP2012526528A (ja) 2012-11-01
EP2429554A1 (en) 2012-03-21
EP2429552A1 (en) 2012-03-21
ZA201109093B (en) 2013-05-29
CA2761444A1 (en) 2010-11-18
JP2012526760A (ja) 2012-11-01
EP2429545A1 (en) 2012-03-21
BRPI1010926A2 (pt) 2016-04-05
ZA201109095B (en) 2015-06-24
US20120107287A1 (en) 2012-05-03
EP2429546A1 (en) 2012-03-21
US8603492B2 (en) 2013-12-10
CN102858354A (zh) 2013-01-02
US8802077B2 (en) 2014-08-12
US20120128726A1 (en) 2012-05-24
BRPI1013731A2 (pt) 2019-09-24
WO2011000621A1 (en) 2011-01-06
JP2012526762A (ja) 2012-11-01
US20120189598A1 (en) 2012-07-26
TW201100087A (en) 2011-01-01
CA2761574A1 (en) 2010-11-18
EP2429556B1 (en) 2016-03-30
WO2010130710A1 (en) 2010-11-18
US20120121563A1 (en) 2012-05-17
US20120135044A1 (en) 2012-05-31
ES2572760T3 (es) 2016-06-02
SG175167A1 (en) 2011-11-28
CN102939093A (zh) 2013-02-20
WO2010133472A2 (en) 2010-11-25
JP2012526755A (ja) 2012-11-01
MX2011012074A (es) 2012-03-07
CN102883731A (zh) 2013-01-16
US20150079056A1 (en) 2015-03-19
US20120121685A1 (en) 2012-05-17
WO2010130699A1 (en) 2010-11-18
MY159273A (en) 2016-12-30
AR076676A1 (es) 2011-06-29
JP2012526757A (ja) 2012-11-01
BRPI1010919A2 (pt) 2019-09-24
JP5860396B2 (ja) 2016-02-16
US10576110B2 (en) 2020-03-03
CA2761655A1 (en) 2010-11-18
BRPI1010929A2 (pt) 2016-04-05
RU2554772C2 (ru) 2015-06-27
EP2429557A2 (en) 2012-03-21
RU2539852C2 (ru) 2015-01-27
BRPI1010836A2 (pt) 2016-04-05
US20120141444A1 (en) 2012-06-07
CA2761598A1 (en) 2010-11-18
MX2011012075A (es) 2012-03-07
JP2012526758A (ja) 2012-11-01
US20120183514A1 (en) 2012-07-19
MX336030B (es) 2016-01-07
ZA201109085B (en) 2013-05-29
WO2010133475A3 (en) 2011-01-27
US20120269789A1 (en) 2012-10-25
US8691244B2 (en) 2014-04-08
EP2429551A1 (en) 2012-03-21
EP2429541A1 (en) 2012-03-21
WO2010133475A2 (en) 2010-11-25
CA2761449A1 (en) 2010-11-18
ES2608651T3 (es) 2017-04-12
WO2010130662A1 (en) 2010-11-18
RU2549934C2 (ru) 2015-05-10
US20120121561A1 (en) 2012-05-17
WO2010130700A1 (en) 2010-11-18
PT2429539T (pt) 2017-01-12
MX2011012063A (es) 2011-12-06
MX341685B (es) 2016-08-30
MX2011012067A (es) 2011-12-06
EP2429557B1 (en) 2016-05-04
MY166552A (en) 2018-07-16
WO2010142504A1 (en) 2010-12-16
EP2429539A1 (en) 2012-03-21
BRPI1010917A2 (pt) 2016-03-15
US8784798B2 (en) 2014-07-22
TW201043238A (en) 2010-12-16
CA2761444C (en) 2018-04-24
WO2010130663A1 (en) 2010-11-18
CN102869365A (zh) 2013-01-09
JP2013526265A (ja) 2013-06-24
WO2010133472A3 (en) 2011-02-03
CA2761687A1 (en) 2010-11-18
US9375454B2 (en) 2016-06-28
US20120121652A1 (en) 2012-05-17
MY173382A (en) 2020-01-21
JP2012526751A (ja) 2012-11-01
UA109876C2 (uk) 2015-10-26
US20120183515A1 (en) 2012-07-19
CN103596578A (zh) 2014-02-19
ES2576831T3 (es) 2016-07-11
CN102762216A (zh) 2012-10-31
CA2761672A1 (en) 2011-01-06
BRPI1010838A2 (pt) 2019-09-24
JP2012526759A (ja) 2012-11-01
JP2012526761A (ja) 2012-11-01
JP2012526529A (ja) 2012-11-01
EP2429538A1 (en) 2012-03-21
EP2429538B1 (en) 2015-10-21
RU2011150202A (ru) 2013-06-20
JP2013526480A (ja) 2013-06-24
RU2011150195A (ru) 2013-06-20
EP2429540A1 (en) 2012-03-21
RU2556124C2 (ru) 2015-07-10
WO2010130704A1 (en) 2010-11-18
WO2010130701A1 (en) 2010-11-18
EP2429556A2 (en) 2012-03-21
EP2429553A1 (en) 2012-03-21
CN102802648A (zh) 2012-11-28
CA2761691A1 (en) 2010-11-18
US8916374B2 (en) 2014-12-23
WO2010130697A1 (en) 2010-11-18
TWI489988B (zh) 2015-07-01
ES2559008T3 (es) 2016-02-10
BRPI1012849A2 (pt) 2018-06-19
PT2429557E (pt) 2016-06-17
BRPI1013733A2 (pt) 2019-09-24
CA2761446A1 (en) 2010-11-18
CA2761573A1 (en) 2010-11-18
BRPI1010839A2 (pt) 2016-04-05
CA2761453A1 (en) 2010-11-25

Similar Documents

Publication Publication Date Title
BRPI1014304A2 (pt) bifidobacterium longum ncc2705 (cncm i-2618) e distúrbios imunes
ZA201202155B (en) Bifidobacterium longum and functional gi disorders
HK1152968A1 (en) New probiotic bifidobacterium longum
PL2498789T3 (pl) Probiotyczny szczep bifidobacterium
PL2352389T3 (pl) Bifidobacterium longum
GB2460781B (en) Probiotic bifidobacterium strains
GB2465051B (en) Probiotic bifidobacterium strains
PT2582377E (pt) L. johnsonii la1, b. longum ncc2705 e distúrbios imunológicos
SG10201406169VA (en) Bifidobacterium longum atcc baa-999 (bl999) and weight control
HK1199694A1 (zh) 益生菌組合物和方法
IL252490A0 (en) Ceramic-ceramic bonding and related methods
PL2481299T3 (pl) Szczepy bifidobacterium bifidum do stosowania w chorobach przewodu pokarmowego
EP2396343A4 (en) MODIFIED VIRUS VECTORS AND METHOD FOR THEIR MANUFACTURE AND USE
DK2464362T3 (da) Probiotisk præparat til forebyggelse eller behandling af mavetarmlidelser hos hunde
ZA200905626B (en) Adjuvants and methods of using them
ZA201504217B (en) Strain of bifidobacterium animalis ssp. animalis
PL2568815T3 (pl) Fermentacja synergistyczna lactobacillus rhamnosus i lactobacillus paracasei podgatunek paracasei
PT2707476E (pt) Estirpe lactobacillus fermentum cect 7472 com propriedades robióticas
EP2398900A4 (en) INSULATED MONOCYTIC POPULATIONS AND ASSOCIATED THERAPEUTIC APPLICATIONS
HK1173393A1 (en) Rhamno-polysaccharide from enterococcus faecium clonal complex 17 and uses thereof 17
TH105927B (th) Bifidobacterium longum และการแสดงออกฮิปโปแคมพาล BDNF
PL380803A1 (pl) Nowy szczep Bifidobacterium longum
RS20100436A3 (en) Indigenous LACTOBACILLUS strains and their use as probiotics
TH109993B (th) สายพันธุ์ lactobacillus rhamnosus
PL384675A1 (pl) Nowe zastosowanie preparatu probiotycznego

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]